Search for: "Umit Inc"
Results 1 - 9
of 9
Sorted by Relevance
|
Sort by Date
19 Feb 2016, 6:09 am
Posted by HLS Forum on Corporate Governance and Financial Regulation, on Friday, February 19, 2016 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of February 12, 2016 to February 18, 2016. 2015 Annual Corporate Governance Review Posted by Rajeev Kumar, Georgeson Inc., on Friday, February 12, 2016 Tags: Board composition, Boards of Directors, Diversity, Engagement, Equity-based compensation, ESG, Executive Compensation,… [read post]
10 Mar 2023, 6:30 am
Wolf, Innisfree M&A Inc., on Monday, March 6, 2023 Tags: discretionary language, ESG, Proxy season, Shareholder elections, special interests, Universal Proxy About 1,500 Empirical Studies Apply the BCF Entrenchment Index Posted by Leeor Ofer (Harvard Law School), on Monday, March 6, 2023 Tags: Board of Directors, E-index, Entrenchment Too Many Managers: The Strategic Use of Titles to Avoid Overtime Payments Posted by Lauren H. [read post]
10 Mar 2023, 6:30 am
Wolf, Innisfree M&A Inc., on Monday, March 6, 2023 Tags: discretionary language, ESG, Proxy season, Shareholder elections, special interests, Universal Proxy About 1,500 Empirical Studies Apply the BCF Entrenchment Index Posted by Leeor Ofer (Harvard Law School), on Monday, March 6, 2023 Tags: Board of Directors, E-index, Entrenchment Too Many Managers: The Strategic Use of Titles to Avoid Overtime Payments Posted by Lauren H. [read post]
7 Oct 2016, 6:01 am
Patton, Duke University, on Sunday, October 2, 2016 Tags: Disclosure, Financial reporting, Fund managers, Fund performance, Hedge funds, Information environment,Misreporting, Reporting regulation, Securities regulation, Systemic risk, Voluntary Disclosure Earnings and the Value of Voting Rights Posted by Umit Gurun, University of Texas at Dallas, and Oğuzhan Karakaş, Boston College, on Monday, October 3, 2016 Tags: Accounting, Cash flows, Control rights, Disclosure, Earnings… [read post]
11 May 2018, 6:01 am
Huber, and Charles Shi, Davis Polk & Wardwell LLP, on Tuesday, May 8, 2018 Tags: Asset management, Corporate Social Responsibility, DOL, Engagement, ERISA, ESG, Fiduciary duties, Institutional Investors, Investment advisers, Proxy voting The Uncertain Role of IPOs in Future Securities Class Actions Posted by Jeff Lubitz, Institutional Shareholder Services, Inc., on Wednesday, May 9, 2018 Tags: Arbitration, Class… [read post]
20 Nov 2020, 6:00 am
Turner, Alliance Of Concerned Investors, on Tuesday, November 17, 2020 Tags: Accounting, Accounting standards, Audits, Disclosure, FASB, Financial reporting, Investor protection, Securities regulation, Transparency Greenwashing Posted by Hao Liang (Singapore Management University), Lin Sun (Fudan University), and Melvyn Teo (Singapore Management University), on Tuesday, November 17, 2020 Tags: Asset management, Climate… [read post]
14 Aug 2020, 6:29 am
Braithwaite, Stikeman Elliott LLP, on Wednesday, August 12, 2020 Tags: Board oversight, Boards of Directors, Caremark, COVID-19, Fiduciary duties, Managmenet, Risk management, Risk oversight IQ from IP: Simplifying Search in Portfolio Choice Posted by Umit Gurun (University of Texas), on Wednesday, August 12, 2020 Tags: EDGAR, Fund managers, Information asymmetries, Information environment, Inside… [read post]
16 Jul 2021, 6:18 am
Gompers (Harvard Business School), and Patrick Sweeney (Harvard Business School), on Tuesday, July 13, 2021 Tags: #MeToo, Compliance & ethics, Corporate culture, Diversity, ESG, Private equity, Reputation, Stakeholders, Venture capital firms Say on Pay: Approval Slides as CEO Pay Rises Posted by Samar Feghhi, Equilar, Inc., on Tuesday, July 13, 2021 Tags: Executive Compensation, Institutional… [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle), (In … [read post]
